APA (7th ed.) Citation

P, L., F, O., AC, L., M, G., MD, O., P, Q., . . . MLK, T. (2022). Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): A multicentre, randomised, phase 2b trial. The Lancet. Child & adolescent health, 6(3), 171. https://doi.org/10.1016/S2352-4642(22)00006-2

Chicago Style (17th ed.) Citation

P, Loke, et al. "Probiotic Peanut Oral Immunotherapy Versus Oral Immunotherapy and Placebo in Children with Peanut Allergy in Australia (PPOIT-003): A Multicentre, Randomised, Phase 2b Trial." The Lancet. Child & Adolescent Health 6, no. 3 (2022): 171. https://doi.org/10.1016/S2352-4642(22)00006-2.

MLA (9th ed.) Citation

P, Loke, et al. "Probiotic Peanut Oral Immunotherapy Versus Oral Immunotherapy and Placebo in Children with Peanut Allergy in Australia (PPOIT-003): A Multicentre, Randomised, Phase 2b Trial." The Lancet. Child & Adolescent Health, vol. 6, no. 3, 2022, p. 171, https://doi.org/10.1016/S2352-4642(22)00006-2.